Download the full article here
Zeal Specialty Pharmacy opened its doors in 2023 with the mission of providing a superior level of service for patients with rare and chronic diseases. By leveraging proprietary technology and the expertise of its leadership team, Zeal was able to quickly earn licensure in all fifty states, along with URAC Specialty Pharmacy and Rare Disease Center of Excellence Accreditation, and ACHC Accreditation with Rare Disease and Orphan Drug Distinctions. These impressive accomplishments underscore their commitment to redefining specialty care for patients nationwide and giving them greater control and support in their healthcare journey.
With their national expansion, it was critical for Zeal Specialty Pharmacy to partner with a packaging and solutions provider that could deliver a higher level of performance and keep their patient’s critical medications stable and secure in transit in a variety of different climates across the United States. This is where MaxQ, based in Stillwater, Oklahoma, was able to help.
”We’ve been searching for the ideal solution for our cold-chain medication fulfillment and somehow, everything always came up short – until we met MaxQ, that is,” stated Jonathan Ogurchak, CEO, Co-Founder, and Pharmacist-in-Charge at Zeal. “Their flexible product offerings, along with their willingness to act as a partner to create the RIGHT solutions, have allowed us to scale more rapidly than we could have expected and created patient-friendly, validated options for getting product around the country.”
Jonathan Ogurchak– Chief Executive Officer & Co-Founder – ZEAL Pharmacy
MaxQ was founded by biomedical scientists, and after becoming one of the world’s leading solutions providers for blood banks, health systems, and even the Department of Defense, their leadership team sought to transform packaging performance for specialty pharmacies.
Our PharmaPack SP has been implemented by several pharmacies across the United States that distribute some of the highest cost and most critical medications available, and have been struggling to meet the rigorous package testing requirements to meet URAC and ACHC Standards. The team at MaxQ fully supports our clients to complete required qualification testing, provides access to sensors and an online portal called MaxConnect to store and assess performance data in real-time, and even takes a consultative approach around the pharmacy’s entire distribution process to help identify potential cost savings. Our engineering team is also able to design packaging solutions to meet specific size and performance needs, which was a tremendous benefit to Zeal Specialty Pharmacy, which dispenses many new Limited Distribution Drugs (LDDs).
When you combine these benefits of partnering with MaxQ with the fact that their solutions are cost competitive, can ship and store flat, perform at a higher level than the competition, and are 75% smaller and 50% lighter to provide exponential savings on shipping costs, they offer value and partnership at a level that is unparalleled in the industry. MaxQ and Zeal Specialty Pharmacy share an unrelenting commitment to the patient and revolutionizing what service and support should be in their respective roles in Specialty Pharmacy, and their continued growth and innovation will help empower one another as they continue to grow.
For more information about Zeal Specialty Pharmacy, please see their website: https://www.zealsp.com/